Biotechnology: Crossing the barrier.
Vastag
Brian
B
D000818:Animals; D001812:Blood-Brain Barrier / Q000378:metabolism*; D001927:Brain Diseases / Q000188:drug therapy*; D002408:Catheters, Indwelling; D002986:Clinical Trials as Topic; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D007276:Injections, Intraventricular; D051101:Neurturin / Q000008:administration & dosage / Q000235:genetics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D011506:Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*
C552629:AGT-190; D051100:Glial Cell Line-Derived Neurotrophic Factor; D051101:Neurturin; D011506:Proteins